Screening, diagnosing and prevention of fetal alcohol syndrome: Is this syndrome treatable?

Developmental Neuroscience

Volumn 32, Issue 2, 2010, Pages 91-100

  Ismail, Sahar ^a   Buckley, Stephanie ^a   Budacki, Ross ^a   Jabbar, Ahmad ^a   Gallicano, G Ian ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Fetal alcohol spectrum disorder; Fetal alcohol syndrome; Prevention

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; ALPHA LAMININ 1; ASPARAGYLALANYLPROLYLVALYLSERYLISOLEUCYLPROLYLGLUTAMINE; BETA INTEGRIN 3; BETA INTEGRIN 5; BETA LAMININ 1; BIOLOGICAL MARKER; BUSPIRONE; CARBOHYDRATE DEFICIENT TRANSFERRIN; COLLAGEN TYPE 4 ALPHA 2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPSILON SARCOGLYCAN; FATTY ACID ESTER; FREE RADICAL; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN ASSOCIATED ACETALDEHYDE; IPSAPIRONE; MATRIX METALLOPROTEINASE; MICRORNA; NEUROPROTECTIVE AGENT; OSTEOPONTIN; PROTEIN TUSP; RAS PROTEIN; SERYLALANYLLEUCYLLEUCYLARGINYLSERYLISOLEUCYLPROLYLALANINE; UNCLASSIFIED DRUG; TERATOGENIC AGENT;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; APOPTOSIS; BIRTH CONTROL; BRAIN MALFORMATION; BREATH ANALYSIS; CELL DAMAGE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CIGARETTE SMOKING; CONTRACEPTION; CRANIOFACIAL MALFORMATION; CULTURAL FACTOR; DNA MICROARRAY; FETAL ALCOHOL SYNDROME; FETAL MALNUTRITION; HUMAN; HYPOXIA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEAN CORPUSCULAR VOLUME; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRENATAL EXPOSURE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SCREENING TEST; SHORT SURVEY; SOCIAL STATUS; TERATOGENICITY; UBIQUITINATION; CHEMICALLY INDUCED; CHILD; DRINKING BEHAVIOR; FAMILY; FEMALE; FETAL ALCOHOL SPECTRUM DISORDERS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PREVENTION AND CONTROL;

ALCOHOL DRINKING; BIOLOGICAL MARKERS; CHILD; ETHANOL; FAMILY; FEMALE; FETAL ALCOHOL SYNDROME; HUMANS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; TERATOGENS; FETAL ALCOHOL SPECTRUM DISORDERS;

EID: 77953334511     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313339     Document Type: Short Survey

References (72)

1. Abel EL, Hannigan JH (1995): Maternal risk factors in fetal alcohol syndrome: provocative and permissive influences. Neurotoxicol Teratol 17: 448-462.
2. Amini S, Merabova N, Khalili K, Darbinian N (2009): p38SJ, a novel DINGG protein, protects neuronal cells from alcohol-induced injury and death. J Cell Physiol 221: 499-504.
3. Astley SJ, Clarren SK, Little RE, Sampson PD, Daling JR (1992): Analysis of facial shape in children gestationally exposed to marijuana, alcohol, and/or cocaine. Pediatrics 89: 67-77.
4. Bearer CF, Santiago LM, O'Riordan MA, Buck K, Lee SC, Singer LT (2005): Fatty acid ethyl esters: quantitative biomarkers for maternal alcohol consumption. J Pediatr 146: 824-830.
5. Becker HC, Randall CL (1989): Effects of prenatal ethanol exposure in C57BL mice on locomotor activity and passive avoidance behavior. Psychopharmacology (Berl) 97: 40-44.
6. Bradley KA, Boyd-Wickizer J, Powell SH, Burman ML (1998): Alcohol screening questionnaires in women: a critical review. JAMA 280: 166-171.
7. Brown NA, Goulding EH, Fabro S (1979): Ethanol embryotoxicity: direct effects on mammalian embryos in vitro. Science 260: 573-575.
8. Camarillo C, Kumar LS, Bake S, Sohrabji F, Miranda RC (2007): Ethanol regulates angiogenic cytokines during neural development: evidence from an in vitro model of mitogenwithdrawal-induced cerebral cortical neuroepithelial differentiation. Alcohol Clin Exp Res 31: 324-335.
9. Camarillo C, Miranda RC (2008): Ethanol exposure during neurogenesis induces persistent effects on neural maturation: evidence from an ex vivo model of fetal cerebral cortical neuroepithelial progenitor maturation. Gene Expr 14: 159-171.
10. Cano MJ, Ayala A, Murillo ML, Carreras O (2001): Protective effect of folic acid against oxidative stress produced in 21-day postpartum rats by maternal-ethanol chronic consumption during pregnancy and lactation period. Free Radic Res 34: 1-8.
11. Centers for Disease Control and Prevention (2009): National Center on Birth Defects and Developmental Disabilities. http://www.cdc. gov/ncbddd (accessed August 24, 2009).
12. Chalmers DM, Levi AJ, Chanarin I, North WR, Meade TW (1979): Mean cell volume in a working population: the effects of age, smoking, alcohol, and oral contraception. Br J Haematol 43: 631-636.
13. Chambaut-Guérin AM, Hérigault S, Rouet-Benzineb P, Rouher C, Lafuma C (2000): Induction of matrix metalloproteinase MMP-9 (92-kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells: relevance to neuronal differentiation. J Neurochem 74: 508-517.
14. Chang C, Yu C, Ko H, Chen C, Chang F (2003): Three-dimensional power Doppler ultrasound for the assessment of the fetal brain blood flow in normal gestation. Ultrasound Med Biol 29: 1273-1279. (Pubitemid 37211327)
15. Chernoff GF (1977): The fetal alcohol syndrome in mice: an animal model. Teratology 15: 223-229.
16. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B (2002): CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26: 332-339.
17. Cook JD (2003): Biochemical markers of alcohol use in pregnant women. Clin Biochem 36: 9-19.
18. Cuzon VC, Yeh PW, Yanagawa Y, Obata K, Yeh HH (2008): Ethanol consumption during early pregnancy alters the disposition of tangentially migrating GABAergic interneurons in the fetal cortex. J Neurosci 28: 1854-1864.
19. Datta S, Turner D, Singh R, Ruest LB, Pierce WM Jr, Knudsen TB (2008): Fetal alcohol syndrome (FAS) in C57BL/6 mice detected through proteomics screening of the amniotic fluid. Birth Defects Res A Clin Mol Teratol 82: 177-186.
20. Davis WL, Crawford LA, Cooper OJ, Farmer GR, Thomas DL, Freeman BL (1990): Ethanol induces the generation of reactive free radicals by neural crest cells in vitro. J Craniofac Genet Dev Biol 10: 277-293.
21. Downing C, Balderrama-Durbin C, Hayes J, Johnson TE, Gilliam D (2009): No effect of prenatal alcohol exposure on activity in three inbred strains of mice. Alcohol Alcohol 44: 25-33.
22. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME (1997): Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665.
23. Dunty WC Jr, Chen SY, Zucker RM, Dehart DB, Sulik KK (2001): Selective vulnerability of embryonic cell populations to ethanol-induced apoptosis: implications for alcoholrelated birth defects and neurodevelopmental disorder. Alcohol Clin Exp Res 25: 1523-1535.
24. Eriksen JL, Druse MJ (2001): Astrocyte-mediated trophic support of developing serotonin neurons: effects of ethanol, buspirone, and S100B. Dev Brain Res 131: 9-15.
25. Fang M, Jaffrey SR, Sawa A, Ye K, Luo X, Snyder SH (2000): Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 28: 183-193.
26. Foshay KM, Gallicano GI (2009): miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. Dev Biol 326: 431-443.
27. Gozes I, Bassan M, Zamostiano R, Pinhasov A, Davidson A, Giladi E, Perl O, Glazner GW, Brenneman DC (1999): A novel signaling molecule for neuropeptide action: activitydependent neuroprotective protein. Ann NY Acad Sci 897: 125-135.
28. 1-glycoprotein. Alcohol Alcohol Suppl 1: 473-476.
29. Haorah J, Ramirez SH, Floreani N, Gorantla S, Morsey B, Persidsky Y (2008): Mechanism of alcohol-induced oxidative stress and neuronal injury. Free Radic Biol Med 45: 1542-1550.
30. Hard ML, Abdolell M, Robinson BH, Koren G (2005): Gene-expression analysis after alcohol exposure in the developing mouse. J Lab Clin Med 145: 47-54.
31. Hazelett SE, Liebelt RA, Brown WJ, Androulakakis V, Arjoura D, Truitt EB (1998): Evaluation of acetaldehyde-modified hemoglobin and other markers of chronic heavy alcohol use: effects of gender and hemoglobin concentration. Alcohol Clin Exp Res 22: 1813-1819.
32. Hock B, Schwarz M, Domke I, Grunert VP, Wuertemberger M, Schiemann U (2005): Validity of carbohydrate-deficient transferrin (%CDT),γ- glutamyltransferase (γ-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction 100: 1477-1486.
33. Houbaviy HB, Murray MF, Sharp PA (2003): Embryonic stem cell-specific MicroRNAs. Dev Cell 5: 351-358.
34. Jones KL, Smith DW, Ulleland CN, Streissguth AP (1973): Pattern of malformation in offspring of chronic alcoholic mothers. Lancet i:1267-1271.
35. Kong L, Chen GD, Zhou X, McGinnis JF, Li F, Cao W (2009): Molecular mechanisms underlying cochlear degeneration in the tubby mouse and the therapeutic effect of sulforaphane. Neurochem Int 54: 172-179.
36. Kotch LE, Chen SY, Sulik KK (1995): Ethanolinduced teratogenesis: free radical damage as a possible mechanism. Teratology 52: 128-136.
37. Krichevsky AM, Sonntag KC, Isacson O, Kosik KS (2006): Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 24: 857-864.
38. Kvigne VL, Leonardson GR, Neff-Smith M, Brock E, Borzelleca J (2004): Characteristics of children who have full or incomplete fetal alcohol syndrome. J Pediatr 145: 635-640.
39. Lawlor MA, Alessi DR (2001): PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114: 2903-2910.
40. Li QZ, Wang CY, Shi JD, Ruan QG, Eckenrode S, Davoodi-Semiromi A, et al (2001): Molecular cloning and characterization of the mouse and human TUSP gene, a novel member of the tubby superfamily. Gene 273: 275-284.
41. Lie DC, Colamarino SA, Song HJ, Désiré L, Mira H, Consiglio A (2005): Wnt signalling regulates adult hippocampal neurogenesis. Nature 437: 1370-1375.
42. Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, Weissman AM (1999): RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci USA 96: 11364-11369.
43. McCarver (2001): ADH2 and CYP2E1 genetic polymorphisms: risk factors for alcohol-related birth defects. Drug Metab Dispos 29: 562-565.
44. McCarver DG, Thomasson HR, Martier SS, Sokol RJ, Li T (1997): Alcohol dehydrogenase-2 * 3 allele protects against alcohol-related birth defects among African-Americans. J Pharmacol Exp Ther 283: 1095-1101.
45. Middaugh LD, Randall CL, Favara JP (1988): Prenatal ethanol exposure in C57 mice: effects on pregnancy and offspring development. Neurotoxicol Teratol 10: 175-180.
46. Missouri Department of Mental Health, Division of Alcohol, and Drug Abuse (1994): Fetal alcohol syndrome. http://www.well. com/user/woa/fsfas.htm (accessed August 7, 2009).
47. Moreland N, la Grange L, Montoya R (2002): Impact of in utero exposure to EtOH on corpus callosum development and paw preference in rats: protective effects of silymarin. BMC Complement Altern Med 2: 10.
48. Mothes HK, Opitz B, Werner R, Clausing P (1996): Effects of prenatal ethanol exposure and early experience on home-cage and open-field activity in mice. Neurotoxicol Teratol 18: 59-65.
49. Niemela O, Israel Y, Mizozi Y, Fukunaga T, Eriksson CG (1990): Hemoglobin-acetaldehyde adducts in human volunteers following acute ethanol ingestion. Alcohol Clin Exp Res 14: 838-841.
50. Nyström M, Peräsalo J, Salaspuro M (1992): Carbohydrate- deficient transferrin (CDT) in serum as a possible indicator of heavy drinking in young university students. Alcohol Clin Exp Res 16: 93-97.
51. Peng Y, Kwok KH, Yang P-H, Ng SS, Liu J, Wong OJ, He ML, Kung HF, Lin MC (2005): Ascorbic acid inhibits ROS production, NF-κB activation and prevents ethanol-induced growth retardation and microencephaly. Neuropharmacology 48: 426-434.
52. Randall CL, Taylor WJ, Walker DW (1977): Ethanol-induced malformations in mice. Alcohol Clin Exp Res 1: 219-224.
53. Reimers MJ, la Du JK, Periera CB, Giovanini J, Tanguay RL (2006): Ethanol-dependent toxicity in zebrafish is partially attenuated by antioxidants. Neurotoxicol Teratol 28: 497-508.
54. Reynaud M, Schellenberg F, Loisquex-Meunier MN, Schwan R, Maradeix B, Planche F (2000): Objective diagnosis of alcohol abuse: compared values of carbohydrate-deficient transferrin (CDT), gamma-glutamyltransferase (GGT), and mean corpuscular volume (MCV). Alcohol Clin Exp Res 24: 1414-1419.
55. Roberson R, Cameroni I, Toso L, Abebe D, Bissel S, Spong CY (2009): Alterations in phosphorylated cyclic adenosine monophosphate response element of binding protein activity: a pathway for fetal alcohol syndrome-related neurotoxicity. Am J Obstet Gynecol 200: 193.e1-193.e5.
56. Sari CY, Zhou FC (2004): Prenatal alcohol exposure causes long-term serotonin neuron deficit in mice. Alcohol Clin Exp Res 28: 941-948.
57. Scanga SE, Ruel L, Binari RC, Snow B, Stambolic V, Bouchard D, et al (2000): The conserved PI3′K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila. Oncogene 19: 3971-3977.
58. Scita G, Tenca P, Frittoli E, Tocchetti A, Innocenti M, Giardina G, et al (2000): Signaling from Ras to Rac and beyond: not just a matter of GEFs. EMBO J 19: 2393-2398.
59. Singh AK, Gupta S, Jiang Y, Younus M, Ramzan M (2009): In vitro neurogenesis from neural progenitor cells isolated from the hippocampus region of the brain of adult rats exposed to ethanol during early development through their alcohol-drinking mothers. Alcohol Alcohol 44: 185-198.
60. Spong CY, Abebe DT, Gozes I, Brenneman DE, Hill JM (2001): Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J Pharmacol Exp Ther 297: 774-779.
61. Stoler JM, Huntington KS, Peterson CM, Peterson KP, Daniel P, Aboagye KK, Lieberman E, Ryan L, Holmes LB (1998): The prenatal detection of significant alcohol exposure with maternal blood markers. J Pediatr 133: 346-352.
62. Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'Malley K, Young JK (2004): Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr 25: 228-238.
63. Suvarna N, Borgland SL, Wang J, Phamluong K, Auberson YP, Bonci A, Ron D (2005): Ethanol alters trafficking and functional Nmethyl-D -aspartate receptor NR2 subunit ratio via H-Ras. J Biol Chem 280: 31450-31459.
64. Swayze VW, Johnson VP, Hanson JW, Piven J, Sato Y, Giedd JN, Mosnik D, Andreasen NC (1997): Magnetic resonance imaging of brain anomalies in fetal alcohol syndrome. Pediatrics 99: 232-240.
65. Vaillant C, Didier-Bazes M, Hutter A, Belin MF, Thomasset N (1999): Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J Neurosci 19: 4994-5004.
66. Vangipuram SD, Grever WE, Parker GC, Lyman WD (2008): Ethanol increases fetal human neurosphere size and alters adhesion molecule gene expression. Alcohol Clin Exp Res 32: 339-347.
67. Verdu J, Buratovich MA, Wilder EL, Birnbaum MJ (1999): Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/ PKB. Nat Cell Biol 1: 500-506.
68. Wang LL, Zhang Z, Li Q, Yang R, Pei X, Xu Y, Wang J, Zhou SF, Li Y (2009): Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation. Hum Reprod 24: 562-579.
69. Wexler EM, Paucer A, Kornblum HI, Plamer TD, Geschwind DH (2009): Endogenous Wnt signaling maintains neural progenitor cell potency. Stem Cells 27: 1130-1141.
70. Winn LM, Wells PG (2002): Evidence for Rasdependent signal transduction in phenytoin teratogenicity. Toxicol Appl Pharmacol 84: 144-152.
71. Zhou FC, Fang Y, Goodlett C (2008): Peptidergic agonists of activity-dependent neurotrophic factor protect against prenatal alcohol-induced neural tube defects and serotonin neuron loss. Alcohol Clin Exp Res 32: 1361-1371.
72. Zhou FC, Sari Y, Li TK, Goodlett C, Azmitia EC (2002): Deviations in brain early serotonergic development as a result of fetal alcohol exposure. Neurotox Res 4: 337-342.